Venetoclax is a BCL-2 inhibitor prescribed for the treatment of certain blood cancers, notably chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML). Operating by inhibiting the B-cell lymphoma-2 (BCL-2) protein, Venetoclax disrupts the survival mechanisms of cancer cells, triggering programmed cell death. It is often utilized in combination with other anti-cancer drugs, particularly in cases where the cancer cells exhibit the 17p deletion genetic abnormality, making them less responsive to standard treatments. The use of Venetoclax is carefully managed by healthcare professionals to ensure its efficacy and monitor potential side effects throughout the treatment course. Buy high quality Venetoclax from Chemicea Pharmaceuticals. Chemicea Pharmaceuticals is one of the leading manufacturer and exporter of Venetoclax

Venetoclax

Venetoclax
Zoom Image
CAT. No. CP-V17000
CAS. No. 1257044-40-8
Mol. F. C45H50ClN7O7S
Mol. Wt. 868.45
Stock Status Custom Synthesis

Product Description


  • Category:Impurity Standards
  • Synonyms:NA
  • Chemical Name:4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide

Request for Quotation : Venetoclax

Please enter pack size
Please enter quantity
Please enter phone number
Enter 10 digit contact number
Enter only number
Please enter your full name
Please enter only alphabets
Please enter company name
Please enter your valid email
Please enter your valid email id
Please select country
Please select state
Please select city

Please select captcha
Please wait...